Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Titel:
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Auteur:
Aikawa, Nadia E Kupa, Leonard V K Pasoto, Sandra G Medeiros-Ribeiro, Ana C Yuki, Emily F N Saad, Carla G S Pedrosa, Tatiana Fuller, Ricardo Shinjo, Samuel K Sampaio-Barros, Percival D Andrade, Danieli C O Pereira, Rosa M R Seguro, Luciana P C Valim, Juliana M L Waridel, Filipe Sartori, Ana Marli C Duarte, Alberto J S Antonangelo, Leila Sabino, Ester C Menezes, Paulo Rossi Kallas, Esper G Silva, Clovis A Bonfa, Eloisa